key: cord-0938504-cda0kh3z
authors: Disbrow, Elizabeth; Stokes, Karen Y.; Ledbetter, Christina; Patterson, James; Kelley, Roger; Pardue, Sibile; Reekes, Tyler; Larmeu, Lana; Batra, Vinita; Yuan, Shuai; Cvek, Urska; Trutschl, Marjan; Kilgore, Phillip; Alexander, J. Steven; Kevil, Christopher G.
title: Plasma hydrogen sulfide: A biomarker of Alzheimer's disease and related dementias
date: 2021-03-12
journal: Alzheimers Dement
DOI: 10.1002/alz.12305
sha: 65e0bbb46e7952a4dbaa1bbd727786ca3a845efa
doc_id: 938504
cord_uid: cda0kh3z

While heart disease remains a common cause of mortality, cerebrovascular disease also increases with age, and has been implicated in Alzheimer's disease and related dementias (ADRD). We have described hydrogen sulfide (H(2)S), a signaling molecule important in vascular homeostasis, as a biomarker of cardiovascular disease. We hypothesize that plasma H(2)S and its metabolites also relate to vascular and cognitive dysfunction in ADRD. We used analytical biochemical methods to measure plasma H(2)S metabolites and MRI to evaluate indicators of microvascular disease in ADRD. Levels of total H(2)S and specific metabolites were increased in ADRD versus controls. Cognition and microvascular disease indices were correlated with H(2)S levels. Total plasma sulfide was the strongest indicator of ADRD, and partially drove the relationship between cognitive dysfunction and white matter lesion volume, an indicator of microvascular disease. Our findings show that H(2)S is dysregulated in dementia, providing a potential biomarker for diagnosis and intervention.

Because Alzheimer's disease (AD) is the most common form of age-related neurological disability, identifying, and treating its underlying causes is a critical health challenge. The etiology of AD is complex and multifactorial, and there is accumulating evidence that cerebrovascular dysfunction makes a significant contribution to dementia pathophysiology. While the amyloid cascade hypothesis suggests that accumulation of amyloid "plaques" and phosphorylated-Tau (p-Tau) "tangles" play mechanistic roles in AD, 1,2 therapies targeting suppression of these factors have not yet proven widely clinically effective. 2 However, there is evidence linking the accumulation of amyloid and p-Tau with cerebrovascular dysfunction. 3 Cerebrovascular disease has been reported in up to 70% of dementia patients upon postmortem examination, 4, 5 underlining the link between the two.

Furthermore, the incidence of both dementia and stroke appear to be increasing in tandem worldwide, 6 reflecting socioeconomic status and its influence on largely modifiable vascular risk factors. The "vascular dysregulation hypothesis" [7] [8] [9] proposes that imbalances between blood flow-based substrate delivery and brain energy requirements intensify common cardiovascular risks for Alzheimer's disease and related dementias (ADRD) including hypertension, 10-12 cerebrovascular disease [13] [14] [15] , and sedentary lifestyle. 16, 17 The current thinking is that cerebrovascular dysfunction occurs early in ADRD, 6 and therefore may be an earlier diagnostic marker and a more fruitful therapeutic target.

I Similarly, a recent review by Emrani et al. concluded that vascular risk factors represent initial precedent insults. 18 For instance, in ADRD, vascular dysfunction can drive inflammation which weakens the blood brain barrier (BBB), potentially initiating a cascade of pathophysiologies leading to AD progression. Specifically, disturbances in BBB integrity may set off a cascade of events including excitotoxic calcium signaling (the "calcium hypothesis" of AD [19] [20] [21] ) and metabolic stresses which progressively damage brain structure/function and culminate in amyloid plaques and p-Tau tangles (see Hachinski 6 for review). Consequently, AD and vascular dementia appear to be overlapping and potentially linked clinical phenomena, rather than discrete disease categories. 18 In fact, Hachinski et al. ( 6 , see Figure 3 ) proposed modifying the "Jack" model of Alzheimer's disease 22 to embrace the cerebral vasculature as an early ADRD target in addition to beta amyloid and Tau. Further, the importance of vascular contributions to ADRD was recently recognized by the National Institute on Aging and the Alzheimer's Association. While brain imaging and cerebrospinal fluid analyses were included in the NIAA comprehensive AT(N) (amyloid, p-Tau, and neurodegeneration) biomarker panel, in 2018 the NIAA recommended adding vascular biomarkers to this panel. 23 Here, we hypothesize that plasma hydrogen sulfide (H 2 S) represents a novel vascular biomarker whose concentration is tightly associated with cognitive dysfunction and disease activity in ADRD.

• We used novel biochemical methods to measure plasma hydrogen sulfide metabolites in ADRD. • Levels of total H 2 S and specific metabolites were increased in ADRD versus controls.

• Cognition, brain volume, and microvascular disease indices were correlated with H 2 S levels • H 2 S is dysregulated in dementia, providing a potential biomarker for diagnosis and intervention. 

There is a growing appreciation for the roles of H 2 S and its metabolites in the regulation of both vascular and neuronal homeostasis. 24 26 and recent work indicates that imbalances in H 2 S metabolism exist in the vascular compartment during several disease states. 24 In the brain, H 2 S acts as a neurotransmitter/second messenger produced following nerve excitation, 27 and modulates NMDA receptors during long term potentiation 28 for memory consolidation. Several cell types within the brain and its vasculature generate H 2 S from cysteine. 29 In the brain parenchyma, H 2 S is produced by the enzyme cystathionine β-synthase (CBS), while cystathionine γ-lyase (CSE) generates H 2 S derived from cerebral microvessels.

Additionally, three biochemical forms of reactive sulfur pools exist: free H 2 S, acid-labile (eg, iron-sulfur clusters) and bound sulfide (eg, persulfides, polysulfides).

We and others have previously described defensive roles for H 2 S in preserving normal brain vasomotion, 30, 31 and cognitive function in experimental models of dementia. 32 33-35 Conversely, H 2 S and its metabolites have been shown to contribute to neurological stress and vascular dysfunction, a deleterious role consistent with our current findings. Here, for the first time we have shown that plasma H 2 S and H 2 S metabolites are elevated in ADRD (Figure 1 ), and levels were associated with both cognitive dysfunction and neuroimaging evidence of microvascular disease ( Figure 2 ). Neuroimaging evidence of microvascular disease is indirect and includes FLAIR white matter lesion volume and brain volume measures of atrophy. 36 These findings indicate that the link between H 2 S imbalance and ADRD may be due, at least in part, to microvascular dysfunction. When we tested this possibility using mediation analysis ( Figure 2D It is noteworthy that plasma H 2 S alone was a powerful discriminator between ADRD and controls, and that a combined approach, including imaging and demographic data, did not further improve the sensitivity and specificity of our decision tree classification model.

The apparent contradictory findings for the role for H 2 S in brainrelated pathologies are consistent with literature on other gasotransmitters such as nitric oxide, where in some pathologies excess nitric oxide has been shown to be deleterious, while in others decreased nitric oxide bioavailability has been reported. 37, 38 The fact that both too little and too much H 2 S can be detrimental to brain health may represent a neuroprotective system that breaks down under pathological conditions. Our work is consistent with studies of Downs' syndrome, a condition with several AD-related features and mechanisms, where elevated H 2 S production has been observed. 39 Schizophrenia models also show elevated levels of the H 2 S/polysulfide producing enzyme "Mpst", and C3H schizophrenic mice which display behavioral deficits show elevated sulfides, 40 suggesting that "sulfide stress" contributes to cognitive dysfunction.

These previous studies support our hypothesis that H 2 S may become dysregulated in ADRD, where vascular and cognitive functions are intimately linked. One possible mechanism through which H 2 S levels are elevated is suggested by the "vascular dysregulation hypothesis," which predicts that cerebral hypoxia contributes to ADRD pathogenesis. Because hypoxia and ischemia are potent inducers of CSE expression and function, 41, 42 age-related vascular deficits in brain oxygenation implicate CSE activity in neuronal dysfunction, particularly in areas of the brain where oxygenation is compromised. 43 Furthermore, hypertension and disturbances in cerebrovascular flow, often seen in ADRD 44 may enhance CSE expression and activity 45, 46 and increase "bound" polysulfide pools. Thus, oxygenation abnormalities may drive H 2 S links to a "vascular dysregulation hypothesis," and anticipate associations between the vascular dysfunction observed in the brain and alterations in circulating H 2 S metabolites in ADRD.

Pathways through which hydrogen sulfide disrupts brain microvasculature How might ADRD disease activity, cognitive dysfunction and neuroimaging be related to sulfides? The answer may lie in early, "silent" BBB disturbances driven by abnormal H 2 S homeostasis. Our group, over the last decade, has investigated several gasotransmitters including H 2 S, nitric oxide and their metabolites as contributors to vascular endothelial barrier failure. 47 We showed that exogenous polysulfide donors (not free sulfide donors) act on endothelial junctions to depress vascular barrier in vitro. We have evidence that such a damaging role for H 2 S metabolites also applies to the BBB, where barrier disruption early after stroke is mediated by H 2 S species. 30 Specifically, our reports on the impact of H 2 S on the brain vasculature revealed a role for CSE-derived H 2 S metabolites in ischemic stroke induced vasodilation/hyperemic response and barrier permeability early during reperfusion. 30 It should be noted that polysulfides can be generated endogenously both by the oxidation of H 2 S, and directly from CSE. Therefore, we examined the role of CSE in basal vascular integrity.

Using CSE-deficient mice, we observed a significant reduction in small was not specific to the brain, as we saw a similar response in the lungs ( Figure 5 ). This multi-organ finding, along with the fact that CSE is primarily found in the vasculature, represents a first step in proving our hypothesis that a vascular source of CSE-derived H 2 S is responsible for the imbalance in H 2 S homeostasis in ADRD.

Although still in need of larger studies, our findings are consistent with a scheme where elevated levels of H 2 S and its metabolites drive barrier disturbances which underlie excitotoxic stress and cognitive injury, particularly in ADRD. 48 In ADRD, disturbances in brain endothelial barrier function can flood the brain interstitium with toxic neurotransmitters, immune components, and iron, each potentially able to trigger a progressive, and calcium-dependent, excitotoxicity ("calcium hypothesis" 6, [19] [20] [21] . Over the course of years, these changes could lead to structural and functional derangement seen in longstanding ADRD.

Our findings reveal that sulfide stress may represent an important indicator of ADRD disease activity which links brain vascular disturbances to cognitive dysfunction, and could provide valuable novel diagnostic, prognostic, and mechanistic insights into ADRD.

We recognize that this study is limited by participant AD diagnosis that is unconfirmed by autopsy. However, even with the possible We also ran the analysis using only the records containing MRI data for comparison (MRI-only). The "All" and "Total H 2 S" facets have duplicated accuracy statistics because in both of these, the same decision tree was generated. We used several measures to classify the accuracy of the classifier. Accuracy describes the probability that the classifier arrives at a correct prediction. Sensitivity describes the probability of correctly predicting a positive condition. Specificity describes the probability of correctly predicting a negative condition. False negative rate and false positive rate indicate the failure of the classifier to correctly categorize positive or negative conditions. Positive predictive value and Negative predictive value represent the reliability of a positive or negative condition respectively. False discovery rate and False omission rate represent the probability that the respective predicted condition does not represent the actual condition heterogeneity of our dementia group, the H 2 S discriminatory power was exceptionally high. Though the groups were small, they were a 

Our initial biomarker studies are highly promising. The well-defined association between blood H 2 S levels and microvascular disease suggest the testable hypothesis that increased generation of H 2 S from CSE, abundant in cerebral microvessels, may drive ADRD progression. Our results showed that total sulfide mediated the relationship between cognitive performance and microvascular related outcomes, F I G U R E 5 CSE knockout mice exhibit reduced vascular permeability. Sodium fluorescein permeability was significantly reduced in the brains (top) and lungs (bottom) of CSE knockout mice compared to wild type controls (*significant P < .05, student's t-test, n = 5/group) supporting a causal role for H 2 S dysregulation in ADRD. Our study indicates that at least some of these H 2 S metabolites, such as oxidized H 2 S, may accumulate in the circulation with deleterious consequences. The fact that powerful group discrimination could be obtained using only a single plasma analyte is remarkable in the ADRD field. These findings suggest further steps are warranted to verify biomarker sensitivity and specificity (see Frisoni et al. Table 3 49 ).

The specificity of H 2 S as a marker of AD as opposed to other forms of dementia, as well as other proteinopathies such as Parkinson disease remains to be determined. Our work also anticipates longitudinal studies for the evaluation of early detection and progression monitoring. The linear nature of the relationships among cognitive, brain volume, and lesion volume measures with total sulfide, as well as acidlabile and bound sulfide pools suggest that H 2 S metabolites may reflect disease progression and could thus have prognostic value. Determining the required interval to detect change for repeated testing, and marker efficacy for early detection are critical goals of future studies for biomarker identification. Based on our observations, it is possible that modulation of plasma sulfides might also represent a therapeutic opportunity in ADRD. It is not clear whether our results will reveal "at-risk" individuals who may go on to develop earlier or more severe disease. However, if modifiable risk factors do contribute to ADRD progression, earlier intervention in such "at-risk" individuals could limit or prevent inevitable progression into clinical ADRD. Because blood sampling remains the easiest, most repeatable and inexpensive method of evaluating biospecimens, reliable blood-based diagnostics for ADRD, as described here, would have an enormous impact in combatting ADRD.

Hydrogen sulfide and its metabolites in ADRD and associated cognitive impairment

The physiology of H 2 S and H 2 S metabolites in ADRD and related neuropathology is not well understood. Since the most accessible pools of H 2 S are in the circulation, our first step was to determine if plasma levels of H 2 S and its metabolites were different in people with and without ADRD. We enrolled 15 participants with ADRD and 42 controls for cognitive and blood testing, and, of these, 12 ADRD and 19 control participants also had MRI (Table 1) . We found that total H 2 S levels increased with ADRD, and that this increase was primarily due to elevations in both acid-labile and bound sulfide pools, not free sulfide ( Figure 1 ). This finding is in contrast to our observations from cardiovascular disease, showing a decline in plasma total, bound, and acidlabile H 2 S levels, 50 thus suggesting a disease mechanism that is unique to the brain. Furthermore, our findings disagree with the only previous study on H 2 S in human AD and vascular dementia, which reported decreased H 2 S levels in plasma. 51 While these apparently conflicting results are consistent with a dual role for H 2 S where both deficient and excessive levels are pathological, our findings also indicate that a redistribution between H 2 S pools may be a critical determinant in the pathological consequences, which none of the previous studies have measured. However, it is also possible some of these conflicting findings relate to the populations studied or the methods used to measure H 2 S. We used an advanced "state of the art" precise method of H 2 S measurement developed by our group which was designed to address limitations of the method used by many others. 50, 52, 53 Of importance from a mechanistic perspective was whether circulating H 2 S metabolite levels correlated with cortical volume and/or white matter lesion volume, both indicators of microvascular health.

To better understand the relative roles for H 2 S in these two interrelated components of ADRD, we used typical diagnostic indices, and correlated them with plasma H 2 S levels. MRI has been widely applied to identify cerebral ventricular and hippocampal volumes as a measure of AD status [39] [40] [41] . As expected, our ADRD population showed decreased hippocampal and increased ventricular volumes. While neither of these indices correlated with levels of H 2 S or individual sulfide pools, there was a clear, inverse relationship between total brain volume and H 2 S levels ( Table 2 ). In addition, the MRI based lesion outcome measure was strongly correlated with both acid-labile and total H 2 S (Table 2) .

Of primary importance from a clinical perspective was quantifying the cognitive impairment that characterizes ADRD. Using the Alzheimer's disease Assessment Scale (ADAS-Cog) score as a measurement of cognitive function, we linked higher ADAS-Cog scores in ADRD, indicative of cognitive dysfunction, with higher H 2 S levels in Specifically, we examined the contribution of H 2 S to the relationship between cognitive function and an indicator microvascular disease.

Total H 2 S was found to drive half of the effect of lesion volume on cognitive function ( Figure 2D ). This finding indicates that H 2 S metabolites may be mechanistically significant as a contributor to ADRD. Importantly, these findings are consistent with cognitive and structural disturbances related to sulfides that originate in the vascular space and act to disrupt vascular homeostasis, leading to downstream neurodegeneration.

ADRD diagnostic tools remain somewhat unreliable and differ in their specificity and sensitivity. The current mainstay of AD diagnosis, the ADAS-cog score has good sensitivity and specificity at 90.09%

and 85.88% respectively 21 . While widely applied, ADAS-cog requires trained operators, is time-consuming and is subject to variability based on patient performance. Hippocampal and ventricular changes on MRI also predict disease activity 42 . Although we found significant diagnostic performance for acid-labile, bound, and total sulfide (Figure 3 ), greater discriminative ability was noted with total sulfide (AUC = 0.94, 95% confidence interval: 0.92 to 1.000; panel 3D). Plasma β-amyloid has also been widely studied as an AD biomarker 43 ; its use in receiver operator characteristic (ROC) curve analysis discriminated AD patients from controls with a specificity/sensitivity of 91% and 71% respectively (AUC = 0.80). Overall, its diagnostic accuracy was good, but not ideal (86%) [43] . The problem with such approaches is that AD diagnosis still remains probabilistic, with the most definitive confirmation only available at autopsy. 54, 5 Low diagnostic accuracy in AD may be related to its complex nature, long course, and variable etiopathogenesis. Thus, the most accurate approach may be a biomarker panel.

For example, Brickman et al. 56 

Cognitive status was evaluated using the MMSE. Dementia was defined as an ADAS-cog score of > 17. 58 The total session duration was 2-4 hours. 

All variables were evaluated across disease groups using multivariate analysis of variance (MANOVA). Pearson correlation was used to evaluate the relationship between H 2 S metabolites and cognitive and imaging outcome measures. These analyses were performed using SPSS version 26.

We used mediation analysis to test the hypothesis that the effect of a predictor variable (% lesion volume) on an outcome (ADAS score) operated fully or in part through an intervening mediator (total sulfide 60 ). Mediation analysis was performed using the PROCESS SPSS macro provided by Hayes and Preacher to perform such analysis. 61 We also performed ROC analysis to illustrate the ability of H 2 S metabolites to distinguish ADRD and control groups using GraphPad Prism v8.4.2 (GraphPad Software, San Diego, California USA). An alpha level of 0.05 was used to determine statistical significance. Outliers were defined as any data point that was > 3SD from the group mean.

To generate decision trees, 57 we used the rpart algorithm (https://cran.r-project.org/web/packages/rpart/rpart.pdf), a regression and classification tree induction algorithm that included the following variables: diagnosis; age; years of education; % hippocampal lesion, and ventricle volume; as well as free, acid-labile, bound, and total H 2 S. We used 10-fold cross-validation to reduce the chances of model overfit.

In addition, we produced a decision tree based on the H 2 S variables alone. Because the control group was larger than the ADRD group the decision tree analysis was performed again using the MRI subgroup.

In vivo endothelial barrier function was evaluated in C57BL/6 J wildtype and CSE knockout mice 47 using Sodium Fluorescein (Na-F; Sigma, Cat. #F-6377) extravasation as described 30 

Detailed results

Participant characteristics are shown in Table 1 . One outlier ADRD subject was excluded based on MRI; therefore, final sample sizes were 15 ADRD and 42 controls. We had an MRI subset of 12 ADRD and 19 controls after one ADRD subject was excluded due to contraindications for MRI and two because of an appointment that was canceled due to COVID-19 closures. There were no significant differences between ADRD and control subjects for age (F (1 

Correlation analysis revealed a significant relationship between H 2 S metabolites and cognitive function ( Figure 2 and Table 2 ). ADAScog score was significantly positively correlated with acid-labile (r(56) = 0.596, P < .0001) and bound sulfane sulfur (r(56) = 0.436, P = .001), as well as total sulfide pools (r(56) = 0.681, P < .0001) ( Figure 2A and Table 2 ) indicating that poorer cognitive performance was associated with higher metabolite levels. FLAIR lesion volume was significantly correlated with ADAS-cog score (r(30) = 0.687, P < .0001) ( Table 2) . Lesion volume was also significantly positively correlated with acid-labile (r(30) = 0.588, P < .0001) and total sulfide (r(30) = 0.452, P < .011) ( Figure 2B ), indicating that greater lesion volume was associated with higher sulfide metabolite levels. Importantly, neither ADAS-cog nor lesion volume were correlated with free sulfide ( Figure 2 and Table 2 ).

Mediation analysis revealed that total H 2 S mediated the effect of lesion volume on cognitive function ( Figure 2C ). First, linear regression results showed that the relationship between % FLAIR lesion volume and total H 2 S was significant (a' , b = 0.0036, SE = 0.0013, P = .0107).

Second, the relationship between total sulfide and ADAS-cog score was 

Using Na-F solute permeation as a measure of vascular barrier function, we found striking improvements in blood-brain barrier of CSE knockout mice compared to wild-type controls ( Figure 5 ). Interestingly, these improvements in barrier were also seen in the lung and therefore appear to reflect a generalized improvement in vascular barrier, which is not limited to the central nervous system, produced by reduction in H 2 S and its metabolites. Mice with this phenotype also have significant reductions in circulating sulfide species. When taken together with our previous report 47 that endothelial cells exposed to per-and polysulfides show significantly diminished solute barrier, these data show that an environmental sulfide burden predicts endothelial barrier dysfunction. Consequently, the finding that our ADRD subjects have significantly higher plasma sulfides is consistent with a hypothesis in which sulfides in the vascular compartment might drive BBB disturbances that contribute to the initiation and progression of ADRD cognitive dysfunction. Our finding that FLAIR signatures in ADRD are consistent with microvascular derangement also fit this "sulfide" model, however future, prospective studies which can validate relationships between the extent of clinical sulfide burden and ADRD disease severity are still required. 

Pathways to Alzheimer's disease

Alzheimer's disease: the amyloid cascade hypothesis

Tau Protein Dysfunction after Brain Ischemia

The overlap between vascular disease and Alzheimer's disease-lessons from pathology

Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline

Preventing dementia by preventing stroke: the Berlin Manifesto

Neurovascular regulation in the normal brain and in Alzheimer's disease

The pathobiology of vascular dementia

Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

Does vascular pathology contribute to Alzheimer's changes?

Hypertension and the risk of mild cognitive impairment

Update on hypertension and Alzheimer's disease

Hypertension and obesity moderate the relationship between beta-amyloid and cognitive decline in midlife

Higher aortic stiffness is related to lower cerebral blood flow and preserved cerebrovascular reactivity in older adults

Atherosclerosis of cerebral arteries in Alzheimer's disease

The projected effect of risk factor reduction on Alzheimer's disease prevalence

Physical activity and Alzheimer's disease: a narrative review

Alzheimer's/Vascular spectrum dementia: classification in addition to diagnosis

Alzheimer's Association Calcium Hypothesis W. Calcium hypothesis of Alzheimer's disease and brain aging: a framework for integrating new evidence into a comprehensive theory of pathogenesis

The role of calcium regulation in brain aging: reexamination of a hypothesis

Calcium hypothesis of Alzheimer's disease and brain aging

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Alzheimer's disease neuroimaging I: understanding disease progression and improving Alzheimer's disease clinical trials: recent highlights from the Alzheimer's disease neuroimaging initiative

The role of hydrogen sulfide on cardiovascular homeostasis: an overview with update on immunomodulation

Effect of hydrogen sulfide on intracellular calcium homeostasis in neuronal cells

Reactive sulfur species: a new redox player in cardiovascular pathophysiology

A source of hydrogen sulfide and a mechanism of its release in the brain

The possible role of hydrogen sulfide as an endogenous neuromodulator

Physiological role of hydrogen sulfide and polysulfide in the central nervous system

Role of hydrogen sulfide in early bloodbrain barrier disruption following transient focal cerebral ischemia

Role of hydrogen sulfide in cognitive deficits: evidences and mechanisms

Neuroprotective effect of hydrogen sulfide in hyperhomocysteinemia is mediated through antioxidant action involving Nrf2

Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms

Mechanisms of hydrogen sulfide against the progression of severe Alzheimer's disease in transgenic mice at different ages

Hydrogen sulfide protects against amyloid beta-peptide induced neuronal injury via attenuating inflammatory responses in a rat model

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

Nitric oxide and the vascular endothelium

The role of nitric oxide in brain disorders: autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders

Endogenous hydrogen sulfide overproduction in down syndrome

Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology

Cystathionine gamma-lyase regulates arteriogenesis through NO-dependent monocyte recruitment

H2S mediates O2 sensing in the carotid body

Remodelling of Ca2+ homeostasis in type I cortical astrocytes by hypoxia: evidence for association with Alzheimer's disease

Hypertension, dietary salt and cognitive impairment

Laminar shear flow increases hydrogen sulfide and activates a nitric oxide producing signaling cascade in endothelial cells

Cystathionine gamma-Lyase modulates flow-dependent vascular remodeling

Hydrogen sulfide metabolism regulates endothelial solute barrier function

Vascular dysfunction-The disregarded partner of Alzheimer's disease

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

Total sulfane sulfur bioavailability reflects ethnic and gender disparities in cardiovascular disease

Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof

Measurement of plasma hydrogen sulfide in vivo and in vitro

Analytical measurement of discrete hydrogen sulfide pools in biological specimens

Prediction of autopsy verified neuropathological change of Alzheimer's disease using machine learning and MRI

Validation of the AD-CSF-index in autopsy-confirmed Alzheimer's disease patients and healthy controls

An MRI measure of degenerative and cerebrovascular pathology in Alzheimer disease

Diagnostic value and functional correlations of the ADAS-Cog scale in Alzheimer's disease: data on NORMACODEM project

An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis

Mediation in experimental and nonexperimental studies: new procedures and recommendations

Plasma hydrogen sulfide: A biomarker of Alzheimer's disease and related dementias

The authors have no conflicts. A provisional patent was filed based on the findings of this study.